These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 20848992

  • 1. Radioprotection from radiation-induced lymphedema without tumor protection.
    Daley SK, Bernas MJ, Stea BD, Bracamonte F, McKenna M, Stejskal A, Hirleman ED, Witte MH.
    Lymphology; 2010 Jun; 43(2):48-58. PubMed ID: 20848992
    [Abstract] [Full Text] [Related]

  • 2. Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.
    Mangoni M, Yue X, Morin C, Violot D, Frascogna V, Tao Y, Opolon P, Castaing M, Auperin A, Biti G, Barritault D, Vozenin-Brotons MC, Deutsch E, Bourhis J.
    Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1242-50. PubMed ID: 19545790
    [Abstract] [Full Text] [Related]

  • 3. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
    Vujaskovic Z, Feng QF, Rabbani ZN, Samulski TV, Anscher MS, Brizel DM.
    Exp Lung Res; 2002 Jul 15; 28(7):577-90. PubMed ID: 12396250
    [Abstract] [Full Text] [Related]

  • 4. Sparing radiation-induced damage to the physis by radioprotectant drugs: laboratory analysis in a rat model.
    Tamurian RM, Damron TA, Spadaro JA.
    J Orthop Res; 1999 Mar 15; 17(2):286-92. PubMed ID: 10221847
    [Abstract] [Full Text] [Related]

  • 5. Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.
    Paine GD, Taylor CW, Lopez MH, Johnson CS, Capizzi RL.
    Semin Oncol; 1996 Aug 15; 23(4 Suppl 8):35-9. PubMed ID: 8783664
    [Abstract] [Full Text] [Related]

  • 6. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
    Mehta V.
    Semin Oncol; 2004 Dec 15; 31(6 Suppl 18):42-6. PubMed ID: 15726522
    [Abstract] [Full Text] [Related]

  • 7. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP, Mehta MP.
    Semin Oncol; 1996 Aug 15; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [Abstract] [Full Text] [Related]

  • 8. The potential influence of cell protectors for dose escalation in cancer therapy: an analysis of amifostine.
    McCumber LM.
    Med Dosim; 2004 Aug 15; 29(2):139-43. PubMed ID: 15191764
    [Abstract] [Full Text] [Related]

  • 9. Protection of normal tissues from the cytotoxic effects of radiation therapy: focus on amifostine.
    Mehta MP.
    Semin Radiat Oncol; 1998 Oct 15; 8(4 Suppl 1):14-6. PubMed ID: 9794996
    [Abstract] [Full Text] [Related]

  • 10. Radiotherapeutic studies with amifostine (Ethyol).
    Wasserman TH.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 11):21-5. PubMed ID: 7973775
    [Abstract] [Full Text] [Related]

  • 11. Lymphedema following axillary lymph node dissection for breast cancer.
    Sakorafas GH, Peros G, Cataliotti L, Vlastos G.
    Surg Oncol; 2006 Nov 15; 15(3):153-65. PubMed ID: 17187979
    [Abstract] [Full Text] [Related]

  • 12. Future development of amifostine as a radioprotectant.
    Werner-Wasik M.
    Semin Oncol; 1999 Apr 15; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [Abstract] [Full Text] [Related]

  • 13. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J, Polgár C, Péley G, Németh G.
    Orv Hetil; 2001 Sep 09; 142(36):1941-50. PubMed ID: 11680099
    [Abstract] [Full Text] [Related]

  • 14. Administration of the cytoprotectant amifostine.
    Lindemann K.
    Clin J Oncol Nurs; 1998 Jul 09; 2(3):101-4. PubMed ID: 10232150
    [Abstract] [Full Text] [Related]

  • 15. Management of the lymph nodes in penile cancer.
    Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H.
    Urology; 2010 Aug 09; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.
    Vuyyuri SB, Hamstra DA, Khanna D, Hamilton CA, Markwart SM, Campbell KC, Sunkara P, Ross BD, Rehemtulla A.
    Clin Cancer Res; 2008 Apr 01; 14(7):2161-70. PubMed ID: 18381958
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Radiation-induced toxicities: the role of radioprotectants.
    Curran WJ.
    Semin Radiat Oncol; 1998 Oct 01; 8(4 Suppl 1):2-4. PubMed ID: 9794993
    [Abstract] [Full Text] [Related]

  • 20. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
    Capizzi RL.
    Semin Oncol; 1999 Apr 01; 26(2 Suppl 7):72-81. PubMed ID: 10348264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.